Drug General Information
Drug ID	D0M3RQ
Former ID	DNC008428
Drug Name	5-(6-hydroxy-2-naphthyl)pyridin-3-ol
Drug Type	Small molecular drug
Indication	Discovery agent		Investigative	[529359]
Structure		Download 2D MOL 3D MOL
Formula	C15H11NO2
Canonical SMILES	C1=CC2=C(C=CC(=C2)O)C=C1C3=CC(=CN=C3)O
InChI	1S/C15H11NO2/c17-14-4-3-10-5-11(1-2-12(10)6-14)13-7-15(18)9-16-8-13/h1-9,17-18H
InChIKey	RTRRNSMMHNFJIV-UHFFFAOYSA-N
PubChem Compound ID	24827431
Target and Pathway
Target(s)	Estradiol 17 beta-dehydrogenase 1	Target Info	Inhibitor	[529359]
BioCyc Pathway	Superpathway of steroid hormone biosynthesis
	Estradiol biosynthesis I
KEGG Pathway	Steroid hormone biosynthesis
	Metabolic pathways
	Ovarian steroidogenesis
NetPath Pathway	FSH Signaling Pathway
PANTHER Pathway	Androgen/estrogene/progesterone biosynthesis
PathWhiz Pathway	Androgen and Estrogen Metabolism
Reactome	The canonical retinoid cycle in rods (twilight vision)
WikiPathways	Steroid Biosynthesis
	Metabolism of steroid hormones and vitamin D
	Prostate Cancer
References
Ref 529359	J Med Chem. 2008 Apr 10;51(7):2158-69. Epub 2008 Mar 7.Design, synthesis, and biological evaluation of (hydroxyphenyl)naphthalene and -quinoline derivatives: potent and selective nonsteroidal inhibitors of 17beta-hydroxysteroid dehydrogenase type 1 (17beta-HSD1) for the treatment of estrogen-dependent diseases.
Ref 529359	J Med Chem. 2008 Apr 10;51(7):2158-69. Epub 2008 Mar 7.Design, synthesis, and biological evaluation of (hydroxyphenyl)naphthalene and -quinoline derivatives: potent and selective nonsteroidal inhibitors of 17beta-hydroxysteroid dehydrogenase type 1 (17beta-HSD1) for the treatment of estrogen-dependent diseases.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.